University of Minnesota. Driven to Discover.
The study of VSV-EBOV hopes to enroll 6,000 health and other frontline workers.
With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.
The small biotech and the drug giant announced an agreement today.
MSF says the outbreak is not over and calls for rapid response teams for hot spots.
An efficacy trial could start in Liberia in December, according to WHO.
Experts today pushed for new ways to test Ebola treatments, and two groups renewed their urgent pleas for aid.
Canada, Britain announce enhanced screening, as officials in Spain probe how a health worker was infected.
Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.
The Ebola total in West Africa's outbreak has pushed past 2,000, as the WHO tempered expectations and addressed food supply issues.
From travel-related measures to the offer of experimental vaccine, African and non-African nations take steps to control spread.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.